Market closed
Kala Pharmaceuticals Inc./$KALA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kala Pharmaceuticals Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Ticker
$KALA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
38
Website
KALA Metrics
BasicAdvanced
$23M
-
-$10.15
-1.72
-
Price and volume
Market cap
$23M
Beta
-1.72
52-week high
$7.97
52-week low
$3.35
Average daily volume
34K
Financial strength
Current ratio
3.114
Quick ratio
3.018
Long term debt to equity
174.635
Total debt to equity
261.531
Interest coverage (TTM)
-6.99%
Management effectiveness
Return on assets (TTM)
-45.36%
Return on equity (TTM)
-388.29%
Valuation
Price to book
1.72
Price to tangible book (TTM)
1.72
Price to free cash flow (TTM)
-0.448
Growth
Earnings per share change (TTM)
-41.53%
3-year earnings per share growth (CAGR)
-54.59%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Kala Pharmaceuticals Inc. stock?
Kala Pharmaceuticals Inc. (KALA) has a market cap of $23M as of April 15, 2025.
What is the P/E ratio for Kala Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for Kala Pharmaceuticals Inc. (KALA) stock is 0 as of April 15, 2025.
Does Kala Pharmaceuticals Inc. stock pay dividends?
No, Kala Pharmaceuticals Inc. (KALA) stock does not pay dividends to its shareholders as of April 15, 2025.
When is the next Kala Pharmaceuticals Inc. dividend payment date?
Kala Pharmaceuticals Inc. (KALA) stock does not pay dividends to its shareholders.
What is the beta indicator for Kala Pharmaceuticals Inc.?
Kala Pharmaceuticals Inc. (KALA) has a beta rating of -1.72. This means that it has an inverse relation to market volatility.